ABOS
Price
$1.04
Change
+$0.04 (+4.00%)
Updated
Jun 3 closing price
Capitalization
63M
75 days until earnings call
FHTX
Price
$4.36
Change
+$0.19 (+4.56%)
Updated
Jun 3 closing price
Capitalization
243.03M
69 days until earnings call
Interact to see
Advertisement

ABOS vs FHTX

Header iconABOS vs FHTX Comparison
Open Charts ABOS vs FHTXBanner chart's image
Acumen Pharmaceuticals
Price$1.04
Change+$0.04 (+4.00%)
Volume$336.23K
Capitalization63M
Foghorn Therapeutics
Price$4.36
Change+$0.19 (+4.56%)
Volume$81.32K
Capitalization243.03M
ABOS vs FHTX Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. FHTX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Buy and FHTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (ABOS: $1.04 vs. FHTX: $4.36)
Brand notoriety: ABOS and FHTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 150% vs. FHTX: 62%
Market capitalization -- ABOS: $63M vs. FHTX: $243.03M
ABOS [@Biotechnology] is valued at $63M. FHTX’s [@Biotechnology] market capitalization is $243.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileFHTX’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • FHTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABOS and FHTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 1 TA indicator(s) are bullish while FHTX’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 1 bullish, 4 bearish.
  • FHTX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, FHTX is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а +1.96% price change this week, while FHTX (@Biotechnology) price change was +7.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

FHTX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FHTX($243M) has a higher market cap than ABOS($63M). FHTX YTD gains are higher at: -7.627 vs. ABOS (-39.535). ABOS has higher annual earnings (EBITDA): -77.89M vs. FHTX (-97.17M). FHTX has more cash in the bank: 244M vs. ABOS (200M). ABOS has less debt than FHTX: ABOS (28.5M) vs FHTX (37.1M). FHTX has higher revenues than ABOS: FHTX (22.6M) vs ABOS (0).
ABOSFHTXABOS / FHTX
Capitalization63M243M26%
EBITDA-77.89M-97.17M80%
Gain YTD-39.535-7.627518%
P/E RatioN/AN/A-
Revenue022.6M-
Total Cash200M244M82%
Total Debt28.5M37.1M77%
TECHNICAL ANALYSIS
Technical Analysis
ABOSFHTX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 20 days ago
77%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 15 days ago
86%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WSMCX15.15N/A
N/A
Allspring Small Company Growth C
FSKLX12.73N/A
N/A
Fidelity SAI Intl Low Volatil Idx
FIQJX22.46N/A
N/A
Fidelity Advisor Intl Sm Cap Opps Z
JIVAX29.90N/A
N/A
JPMorgan U.S. Applied Data Sci Val A
PAHTX6.77N/A
N/A
PGIM Jennison NextGeneration Glb Opps C

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with FHTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+4.00%
FHTX - ABOS
50%
Loosely correlated
+4.56%
BEAM - ABOS
49%
Loosely correlated
+4.26%
ALEC - ABOS
49%
Loosely correlated
+7.25%
ATOS - ABOS
49%
Loosely correlated
-1.68%
ABCL - ABOS
49%
Loosely correlated
+7.94%
More

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with ABOS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
+4.56%
ABOS - FHTX
51%
Loosely correlated
+4.00%
NAUT - FHTX
50%
Loosely correlated
+4.92%
IMNM - FHTX
49%
Loosely correlated
+2.21%
GBIO - FHTX
47%
Loosely correlated
+3.72%
XNCR - FHTX
46%
Loosely correlated
+6.53%
More